Table 5 Primary diagnoses on ICD code block level among 472 older adults (225 women and 247 men) with Down syndrome with at least one visit in planned and unplanned care. Only diagnoses within blocks recorded for at least 10 people are included (planned and unplanned separately)
Planned | Unplanned | |||||||
|---|---|---|---|---|---|---|---|---|
n (%) | Median | Q1-Q3 | Min-Max | n (%) | Median | Q1-Q3 | Min-Max | |
Other bacterial diseases (A30-A49) | ||||||||
Total | 1 (0.2) | 1 | 1–1 | 1–1 | 25 (5.3) | 1 | 1–1 | 1–4 |
Women | 9 (4.0) | 1 | 1–1 | 1–1 | ||||
Men | 16 (6.5) | 1 | 1–1 | 1–4 | ||||
Diabetes mellitus (E10-E14) | ||||||||
Total | 15 (3.2) | 1 | 1–3 | 1–11 | ||||
Women | 8 (3.6) | 1 | 1–2 | 1–11 | ||||
Men | 7 (2.8) | 2 | 1–3 | 1–3 | ||||
Organic, including symptomatic, mental disorders (F00-F09) | ||||||||
Total | 23 (4.9) | 1 | 1–1 | 1–2 | ||||
Women | 14 (6.2) | 1 | 1–1 | 1–2 | ||||
Men | 9 (3.6) | 1 | 1–1 | 1–2 | ||||
Mental retardation (F70-F79) | ||||||||
Total | 55 (11.7) | 1 | 1–2 | 1–6 | ||||
Women | 28 (12.4) | 1 | 1–2 | 1–6 | ||||
Men | 27 (10.9) | 1 | 1–3 | 1–6 | ||||
Other degenerative diseases of the nervous system (G30-G32) | ||||||||
Total | 14 (3.0) | 1 | 1–2 | 1–3 | ||||
Women | 9 (4.0) | 1 | 1–2 | 1–2 | ||||
Men | 5 (2.0) | 1 | 1–1 | 1–3 | ||||
Episodic and paroxysmal disorders (G40-G47) | ||||||||
Total | 43 (9.1) | 1 | 1–2 | 1–6 | 61 (12.9) | 1 | 1–2 | 1–30 |
Women | 32 (14.2) | 1 | 1–2 | 1–6 | 39 (17.3) | 1 | 1–2 | 1–30 |
Men | 11 (4.5) | 1 | 1–2 | 1–3 | 22 (8.9) | 1 | 1–1 | 1–4 |
Disorders of conjunctiva (H10-H13) | ||||||||
Total | 14 (3.0) | 1 | 1–1 | 1–4 | ||||
Women | 7 (3.1) | 1 | 1–1 | 1–4 | ||||
Men | 7 (2.8) | 1 | 1–1 | 1–1 | ||||
Disorders of sclera, cornea, iris and ciliary body (H15-H22) | ||||||||
Total | 24 (5.1) | 1 | 1–2 | 1–4 | ||||
Women | 9 (4.0) | 2 | 1–2 | 1–4 | ||||
Men | 15 (6.1) | 1 | 1–3 | 1–4 | ||||
Disorders of lens (H25-H28) | ||||||||
Total | 136 (28.8) | 1 | 1–2 | 1–4 | ||||
Women | 80 (35.6) | 1 | 1–2 | 1–4 | ||||
Men | 56 (22.7) | 1 | 1–2 | 1–3 | ||||
Disorders of ocular muscles, binocular movement, accommo-dation and refraction (H49-H52) | ||||||||
Total | 19 (4.0) | 1 | 1–1 | 1–3 | ||||
Women | 13 (5.8) | 1 | 1–1 | 1–2 | ||||
Men | 6 (2.4) | 1 | 1–1 | 1–3 | ||||
Diseases of external ear (H60-H62) | ||||||||
Total | 21 (4.4) | 1 | 1–2 | 1–7 | ||||
Women | 9 (4.0) | 1 | 1–1 | 1–3 | ||||
Men | 12 (4.9) | 1 | 1–2 | 1–7 | ||||
Other disorders of ear (H90-H95) | ||||||||
Total | 10 (2.1) | 1 | 1–1 | 1–2 | ||||
Women | 3 (1.3) | 1 | 1–1 | 1–1 | ||||
Men | 7 (2.8) | 1 | 1–1 | 1–2 | ||||
Ischaemic heart diseases (I20-I25) | ||||||||
Total | 11 (2.3) | 1 | 1–1 | 1–3 | ||||
Women | 5 (2.2) | 1 | 1–1 | 1–3 | ||||
Men | 6 (2.4) | 1 | 1–1 | 1–2 | ||||
Other forms of heart disease (I30-I52) | ||||||||
Total | 14 (3.0) | 1 | 1–1 | 1–2 | 25 (5.3) | 1 | 1–1 | 1–2 |
Women | 6 (2.7) | 1 | 1–2 | 1–2 | 12 (5.3) | 1 | 1–1 | 1–1 |
Men | 8 (3.2) | 1 | 1–1 | 1–1 | 13 (5.3) | 1 | 1–1 | 1–2 |
Cerebrovascular diseases (I60-I69) | ||||||||
Total | 19 (4.0) | 1 | 1–1 | 1–1 | ||||
Women | 10 (4.4) | 1 | 1–1 | 1–1 | ||||
Men | 9 (3.6) | 1 | 1–1 | 1–1 | ||||
Acute upper respiratory infections(J00-J06) | ||||||||
Total | 16 (3.4) | 1 | 1–1 | 1–3 | ||||
Women | 6 (2.7) | 1 | 1–1 | 1–1 | ||||
Men | 10 (4.0) | 1 | 1–1 | 1–3 | ||||
Influenza and pneumonia (J09-J18) | ||||||||
Total | 10 (2.1) | 1 | 1–1 | 1–2 | 118 (25.0) | 1 | 1–2 | 1–5 |
Women | 4 (1.8) | 1 | 1–2 | 1–2 | 41 (18.2) | 1 | 1–2 | 1–5 |
Men | 6 (2.4) | 1 | 1–1 | 1–1 | 77 (31.2) | 1 | 1–2 | 1–4 |
Other acute lower respiratory infections (J20-J22) | ||||||||
Total | 14 (3.0) | 1 | 1–1 | 1–2 | ||||
Women | 9 (4.0) | 1 | 1–2 | 1–2 | ||||
Men | 5 (2.0) | 1 | 1–1 | 1–1 | ||||
Lung diseases due to external agents (J60-J70) | ||||||||
Total | 13 (2.8) | 1 | 1–1 | 1–2 | ||||
Women | 6 (2.7) | 1 | 1–1 | 1–2 | ||||
Men | 7 (2.8) | 1 | 1–1 | 1–1 | ||||
Diseases of oesophagus, stomach and duodenum (K20-K31) | ||||||||
Total | 19 (4.0) | 1 | 1–1 | 1–2 | 21 (4.4) | 1 | 1–1 | 1–6 |
Women | 8 (3.6) | 1 | 1–1 | 1–1 | 11 (4.9) | 1 | 1–1 | 1–6 |
Men | 11 (4.5) | 1 | 1–1 | 1–2 | 10 (4.0) | 1 | 1–1 | 1–5 |
Hernia (K40-K46) | ||||||||
Total | 29 (6.1) | 1 | 1–2 | 1–2 | 12 (2.5) | 1 | 1–1 | 1–1 |
Women | 6 (2.7) | 1 | 1–2 | 1–2 | 1 (0.4) | 1 | 1–1 | 1–1 |
Men | 23 (9.3) | 1 | 1–2 | 1–2 | 11 (4.5) | 1 | 1–1 | 1–1 |
Noninfective enteritis and colitis (K50-K52) | ||||||||
Total | 11 (2.3) | 1 | 1–2 | 1–6 | ||||
Women | 8 (3.6) | 1 | 1–3 | 1–6 | ||||
Men | 3 (1.2) | 2 | 2–2 | 2–2 | ||||
Other diseases of intestines (K55-K63) | ||||||||
Total | 22 (4.7) | 1 | 1–2 | 1–5 | 30 (6.4) | 1 | 1–2 | 1–9 |
Women | 16 (7.1) | 1 | 1–2 | 1–4 | 17 (7.6) | 1 | 1–2 | 1–9 |
Men | 6 (2.4) | 1 | 1–2 | 1–5 | 13 (5.3) | 1 | 1–1 | 1–3 |
Disorders of gallbladder, biliary tract and pancreas (K80-K87) | ||||||||
Total | 12 (2.5) | 1 | 1–1 | 1–3 | ||||
Women | 5 (2.2) | 1 | 1–1 | 1–3 | ||||
Men | 7 (2.8) | 1 | 1–1 | 1–3 | ||||
Other diseases of the digestive system (K90-K93) | ||||||||
Total | 19 (4.0) | 1 | 1–1 | 1–3 | ||||
Women | 6 (2.7) | 1 | 1–1 | 1–2 | ||||
Men | 13 (5.3) | 1 | 1–1 | 1–3 | ||||
Arthropathies (M00-M25) | ||||||||
Total | 56 (11.9) | 2 | 2 | 6 | 27 (5.7) | 1 | 1 | 3 |
Women | 37 (16.4) | 2 | 2 | 5 | 15 (6.7) | 1 | 1 | 3 |
Men | 19 (7.7) | 1 | 2 | 6 | 12 (4.9) | 1 | 1 | 2 |
Soft tissue disorders related to use, overuse and pressure (M70-M79) | ||||||||
Total | 29 (6.1) | 1 | 1–1 | 1–2 | ||||
Women | 15 (6.7) | 1 | 1–1 | 1–2 | ||||
Men | 14 (5.7) | 1 | 1–1 | 1–2 | ||||
Disorders of bone density and structure (M80-M85) | ||||||||
Total | 11 (2.3) | 2 | 1–2 | 1–3 | ||||
Women | 6 (2.7) | 2 | 1–2 | 1–3 | ||||
Men | 5 (2.0) | 2 | 2–2 | 1–2 | ||||
Renal tubulo-interstitial diseases (N10-N16) | ||||||||
Total | 11 (2.3) | 1 | 1–1 | 1–2 | ||||
Women | 4 (1.8) | 1 | 1–1 | 1–1 | ||||
Men | 7 (2.8) | 1 | 1–1 | 1–2 | ||||
Other diseases of urinary system (N30-N39) | ||||||||
Total | 39 (8.3) | 1 | 1–1 | 1–6 | ||||
Women | 20 (8.9) | 1 | 1–2 | 1–6 | ||||
Men | 19 (7.7) | 1 | 1–1 | 1–2 | ||||
Non-inflammatory disorders of female genital tract (N80-N98) | ||||||||
Total | 12 (2.5) | 1 | 1–1 | 1–1 | ||||
Women | 12 (5.3) | 1 | 1–1 | 1–1 | ||||
Men | 0 (0) | |||||||
Congenital malformations of the circulatory system (Q20-Q28) | ||||||||
Total | 10 (2.1) | 1 | 1–2 | 1–5 | ||||
Women | 5 (2.2) | 1 | 1–1 | 1–2 | ||||
Men | 5 (2.0) | 2 | 1–2 | 1–5 | ||||
Chromosomal abnormalities, not elsewhere classified (Q90-Q99) | ||||||||
Total | 108 (22.9) | 1 | 1–1 | 1–3 | 33 (7.0) | 1 | 1–1 | 1–3 |
Women | 53 (23.6) | 1 | 1–1 | 1–3 | 19 (8.4) | 1 | 1–1 | 1–2 |
Men | 55 (22.3) | 1 | 1–1 | 1–3 | 14 (5.7) | 1 | 1–1 | 1–3 |
Symptoms and signs involving the circulatory and respiratory systems (R00-R09) | ||||||||
Total | 29 (6.1) | 1 | 1–1 | 1–7 | ||||
Women | 8 (3.6) | 2 | 1–3 | 1–7 | ||||
Men | 21 (8.5) | 1 | 1–1 | 1–3 | ||||
Symptoms and signs involving the digestive system and abdomen (R10-R19) | ||||||||
Total | 18 (3.8) | 1 | 1–1 | 1–4 | 64 (13.6) | 1 | 1–1 | 1–25 |
Women | 12 (5.3) | 1 | 1–2 | 1–4 | 35 (15.6) | 1 | 1–2 | 1–25 |
Men | 6 (2.4) | 1 | 1–1 | 1–1 | 29 (11.7) | 1 | 1–1 | 1–2 |
General symptoms and signs (R50- R69) | ||||||||
Total | 68 (14.4) | 1 | 1–1 | 1–5 | ||||
Women | 38 (16.9) | 1 | 1–1 | 1–5 | ||||
Men | 30 (12.1) | 1 | 1–1 | 1–2 | ||||
Injuries to the head (S00-S09) | ||||||||
Total | 29 (6.1) | 1 | 1–1 | 1–3 | ||||
Women | 19 (8.4) | 1 | 1–1 | 1–3 | ||||
Men | 10 (4.0) | 1 | 1–1 | 1–3 | ||||
Injuries to abdomen, lower back, lumbar spine and pelvis (S30-S39) | ||||||||
Total | 10 (2.1) | 1 | 1–1 | 1–2 | ||||
Women | 7 (3.1) | 1 | 1–2 | 1–2 | ||||
Men | 3 (1.2) | 1 | 1–1 | 1–1 | ||||
Injuries to the shoulder and upper arm (S40-S49) | ||||||||
Total | 10 (2.1) | 1 | 1–1 | 1–2 | 15 (3.2) | 1 | 1–1 | 1–2 |
Women | 7 (3.1) | 1 | 1–1 | 1–2 | 10 (4.4) | 1 | 1–1 | 1–1 |
Men | 3 (1.2) | 1 | 1–1 | 1–1 | 5 (2.0) | 1 | 1–1 | 1–2 |
Injuries to the elbow and forearm (S50-S59) | ||||||||
Total | 14 (3.0) | 1 | 1–1 | 1–2 | ||||
Women | 7 (3.1) | 1 | 1–2 | 1–2 | ||||
Men | 7 (2.8) | 1 | 1–1 | 1–1 | ||||
Injuries to the hip and thigh (S70-S79) | ||||||||
Total | 16 (3.4) | 1 | 1–2 | 1–2 | 53 (11.2) | 1 | 1–2 | 1–3 |
Women | 12 (5.3) | 1 | 1–2 | 1–2 | 26 (11.6) | 1 | 1–2 | 1–3 |
Men | 4 (1.6) | 1 | 1–1 | 1–1 | 27 (10.9) | 1 | 1–1 | 1–2 |
Injuries to the knee and lower leg (S80-S89) | ||||||||
Total | 23 (4.9) | 1 | 1–1 | 1–2 | 39 (8.3) | 1 | 1–1 | 1–4 |
Women | 13 (5.8) | 1 | 1–1 | 1–2 | 28 (12.4) | 1 | 1–1 | 1–4 |
Men | 10 (4.0) | 1 | 1–1 | 1–2 | 11 (4.5) | 1 | 1–2 | 1–3 |
Injuries to the ankle and foot (S90-S99) | ||||||||
Total | 20 (4.2) | 1 | 1–1 | 1–1 | ||||
Women | 9 (4.0) | 1 | 1–1 | 1–1 | ||||
Men | 11 (4.5) | 1 | 1–1 | 1–1 | ||||
Effects of foreign body entering through natural orifice (T15-T19) | ||||||||
Total | 24 (5.1) | 1 | 1–1 | 1–2 | ||||
Women | 7 (3.1) | 1 | 1–1 | 1–2 | ||||
Men | 17 (6.9) | 1 | 1–1 | 1–2 | ||||
Health services for examination and investigation (Z00-Z13) | ||||||||
Total | 62 (13.1) | 1 | 1–1 | 1–3 | 19 (4.0) | 1 | 1–1 | 1–3 |
Women | 36 (16.0) | 1 | 1–1 | 1–3 | 6 (2.7) | 1 | 1–2 | 1–3 |
Men | 26 (10.5) | 1 | 1–1 | 1–2 | 13 (5.3) | 1 | 1–1 | 1–1 |
Health services for specific proce-dures and health care (Z40-Z54) | ||||||||
Total | 12 (2.5) | 1 | 1–1 | 1–6 | ||||
Women | 5 (2.2) | 1 | 1–1 | 1–1 | ||||
Men | 7 (2.8) | 1 | 1–1 | 1–6 | ||||
Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z80-Z99) | ||||||||
Total | 17 (3.6) | 1 | 1–1 | 1–4 | ||||
Women | 10 (4.4) | 1 | 1–2 | 1–4 | ||||
Men | 7 (2.8) | 1 | 1–1 | 1–1 | ||||